Ondansetron and pruritus in chronic liver disease: A controlled study

Hepato-Gastroenterology

Volumn 54, Issue 76, 2007, Pages 1196-1199

  Jones, E Anthony ^a   Molenaar, Hugo A J ^a   Oosting, Johannes ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chronic liver disease; Pruritus; Scratching activity; Serotonin antagonist

Indexed keywords

ONDANSETRON; PLACEBO; SEROTONIN 3 RECEPTOR; URSODEOXYCHOLIC ACID;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; BILE DUCT DISEASE; BILE DUCT PRURITUS; BLURRED VISION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; MALE; MEASUREMENT; METHODOLOGY; NAUSEA; NERVE CELL; NEUROTRANSMISSION; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCRATCHING; SEROTONINERGIC TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTIPRURITICS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; ONDANSETRON; PRURITUS; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 34347347288     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jones EA, Bergasa NV: The pruritus of cholestasis. Hepatology 1999; 29:1003-1006.
2. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, et al: Effects of naloxone infusions in patients with the pruritus of cholestasis: A double-blind randomized controlled trial. Ann Intern Med 1995; 123:161-167.
3. Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA: Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. J Amer Acad Dermatol 1999; 41:431-434.
4. Fischer DA, Wright TL: Pruritus as a symptom of hepatitis C: J Amer Acad Dermatol 1994; 30:629-632.
5. Richardson BP: Serotonin and nociception. Ann NY Acad Sci 1990; 600:511-520.
6. Tao R, Auerbach SB: Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharm Exp Ther 2002; 303:540-556.
7. Kjellberg F, Tramer MR: Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001; 18:346-357.
8. Schworer H, Ramadori G: Cholestatic pruritus - pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists. Z Gastroenterol 1995; 33:265-274.
9. Muller C, Pongretz S, Pidlich J, Penner J, Kaider A, Schemper M, et al: Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998; 10:865-870.
10. Schworer H, Hartmann H, Ramadori G: Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain 1995; 61:33-37.
11. O'Donahue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R: A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Parmacol Ther 2005; 21:1041-1045.
12. Molenaar HAJ, Oosting J, Jones EA: Improved device for measuring scratching activity in patients with pruritus. Med Biol Engineer Comput 1998; 36:220-224.
13. McCormack HM, de L'Horne DJ, Sheather S: Clinical applications of visual analogue scales: a critical review. Psychol Med 1988; 18:1007-1019.